Since the beginning of 2014, nearly 800 different VC investors have completed at least one biotech investment globally, according to the PitchBook Platform. The total value of the 1,035 deals during the timeframe checks in at $20.2 billion, with $9.8 billion invested in the space during 2015 alone. In the past 12 months, 16 firms have made double-digit investments—with OrbiMed (12 deals) leading the way—and since 2014, 44 firms have completed 10 or more biotech deals. Of the VCs active in the sector, 161 manage between $100 million and $500 million in assets, while 94 manage at least $1 billion.
Here are the most active VC investors in biotech since the start of 2014, along with their investment counts: